Investment

Details

Preclinical development of a new class of Plasmodium DHODH inhibitor for the treatment of malaria
  • RFP Year
    2018
  • Awarded Amount
    $4,214,187
  • Disease
    Malaria
  • Intervention
    Drug
  • Development Stage
    Lead Optimization
  • Collaboration Partners
    Eisai Co., Ltd., Broad Institute

Introduction and Background of the Project

The detail will be updated soon.